Orbit Discovery, a provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company, have extended their research collaboration to find novel targeting peptides for radiopharmaceutical delivery. This collaboration expands upon a previous agreement designed to enable the identification of high-affinity peptide ligands optimized for precision therapeutic applications.   The expanded collaboration will leverage Orbit Discovery’s proprietary screening platform to ...